Peijia Medical Ltd. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
No of Months
12
12
12
12
12
12
Profit Before Tax
-219.00
-240.00
-432.00
-462.00
-692.00
-2,324.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
131.00
172.00
-290.00
79.00
16.00
-67.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
-11.00
23.00
-651.00
-440.00
-525.00
-201.00
Cash Flow from Investing Activities
-314.00
-170.00
-426.00
-538.00
-511.00
-18.00
Cash Flow from Financing Activities
188.00
0.00
100.00
139.00
894.00
2,634.00
Net Cash Inflow / Outflow
-140.00
-139.00
-965.00
-728.00
-195.00
2,195.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
-4.00
6.00
11.00
111.00
-51.00
-219.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in HKD Million
Seasonal companies are compared with the same quarter last year
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Peijia Medical Ltd.
Figures in Million
consolidated Cash Flow Results
Change(HKD)
Change(%)
Profit Before Tax
-219.723350385033
-295.753861289543
76.00
25.71%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
131.38133017608
72.076338694855
59.00
82.28%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
-11.066476474854
-82.736118905688
71.00
86.62%
Cash Flow from Investing Activities
-314.637582220565
6.46918190636046
-320.00
-4963.64%
Cash Flow from Financing Activities
188.768884337868
-20.9562450924733
208.00
1000.78%
Net Cash Inflow / Outflow
-140.991291764053
-106.918821026061
-34.00
-31.87%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
-4.05611740650262
-9.69563893426027
5.00
58.17%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Dec'25
YoY Growth in year ended Dec 2025 is -148.11% vs 103.53% in Dec 2024
Dec'25
Dec'24
Change(%)
Cash Flow from Operating Activities
-11.07
23.00
-148.11%






